HDAC3 and breast cancer: The expression patterns of HDAC1, HDAC2, and HDAC3 have been evaluated in different types of cancers, including gastric cancer [31], liver cancer [32], prostate cancer [33], breast cancer [34], renal cell cancer [35], ovarian [36] and endometrial carcinomas [37].